Europe — EMA
Druniler
Learn about Druniler febuxostat, an oral xanthine oxidase inhibitor for gout and hyperuricemia, including uses, side effects, precautions, and drug interactions.
Request sourcing
What is Febuxostat?
Druniler is a prescription medication that contains the active ingredient febuxostat, a selective non‑purine xanthine oxidase inhibitor, supplied in an oral dosage form (strength not specified). It is marketed in the European Union and belongs to the drug class of xanthine oxidase inhibitors, used to manage conditions associated with elevated uric acid levels such as gout and hyperuricemia, and may be prescribed by healthcare professionals following appropriate evaluation.
What is Febuxostat used for?
Druniler is indicated for the long‑term management of conditions characterized by excess uric acid.
- Treatment of gout in patients with hyperuricemia. - Prevention of gout flares in patients receiving urate‑lowering therapy. - Management of chronic hyperuricemia in patients with or without gout. - Adjunct therapy when diet and lifestyle modifications are insufficient to control serum uric acid.
What are the side effects of Febuxostat?
The safety profile of Druniler includes a range of observed adverse events, which are categorized by frequency.
Common: - Headache. - Nausea or vomiting. - Diarrhea. - Elevated liver enzymes.
Serious: - Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome). - Liver injury or hepatitis. - Cardiovascular events such as myocardial infarction.
What precautions apply to Febuxostat?
Before initiating Druniler, several precautionary measures should be considered to minimize risk.
- Assess renal and hepatic function prior to therapy. - Adjust dose in patients with moderate to severe renal impairment. - Monitor serum uric acid levels regularly during treatment. - Use caution in patients with a history of cardiovascular disease. - Avoid use during pregnancy and lactation unless benefits outweigh risks. - Review concomitant medications that may affect uric acid metabolism.
What does Febuxostat interact with?
Druniler may interact with other medicines; some combinations should be avoided while others require careful monitoring.
Avoid: - Strong azole antifungals (e.g., ketoconazole) that inhibit CYP enzymes. - High‑dose aspirin, which may reduce febuxostat efficacy.
Use with caution: - Warfarin, as febuxostat may increase INR. - Azathioprine or mercaptopurine, due to potential increased toxicity. - Simvastatin, because of a possible increased risk of myopathy.
Frequently asked questions
What is the mechanism of action of febuxostat in Druniler?+
Is Druniler approved for use in the United States?+
Can Druniler be taken with food?+
How often should serum uric acid be monitored while on Druniler?+
What should a patient do if they miss a dose of Druniler?+
Is dose adjustment required for patients with kidney problems?+
Does Druniler affect blood pressure or heart rate?+
Can Druniler be used during pregnancy or breastfeeding?+
What lifestyle changes complement Druniler therapy for gout?+
Are there any over‑the‑counter products that should be avoided with Druniler?+
How long does it typically take to see a reduction in uric acid levels with Druniler?+
What are the signs of a serious allergic reaction to Druniler?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo